The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock

Yu-Tzu Tien1, Wen-Jone Chen1,2, Chien-Hua Huang1

  • 1Department of Emergency Medicine, National Taiwan University Medical College and Hospital, Taipei City, Taiwan.

Insights

A new Cardiogenic Shock Prognosis (CSP) score predicts in-hospital mortality in acute myocardial infarction patients. This tool aids clinicians in identifying high-risk individuals for better outcomes.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Prognostic Modeling

Background:

  • Cardiogenic shock (CS) is a primary cause of mortality post-acute myocardial infarction (AMI).
  • Existing mortality prediction scores may not capture nonlinear clinical trajectories.
  • There is a need to explore factors during acute care for improved CS risk assessment.

Purpose of the Study:

  • To develop and validate a risk-predictive model for in-hospital mortality in patients experiencing cardiogenic shock.
  • To identify independent prognostic factors contributing to mortality in CS patients.

Main Methods:

  • An observational study enrolled 311 adult patients with CS requiring inotropic support in the Emergency Room (ER).
  • Patients were divided into derivation (n=243) and validation (n=68) cohorts.
  • Exclusion criteria included out-of-hospital cardiac arrest and short survival post-ER arrival.

Main Results:

  • Key predictors of mortality included: prior coronary artery disease, multiple inotropes, low ejection fraction (<40%), low hemoglobin, prolonged CPR, albumin infusion, and renal replacement therapy.
  • The Cardiogenic Shock Prognosis (CSP) score was developed, categorizing patients into low (0% mortality), medium (8.75% mortality), and high-risk (66.67% mortality) groups.
  • The CSP score demonstrated strong predictive accuracy (AUC=0.941 in derivation, AUC=0.813 in validation).

Conclusions:

  • The CSP score serves as a valuable tool for predicting in-hospital mortality in CS patients within acute care settings.
  • Identification of high-risk patients via the CSP score can guide clinical management and potentially improve prognosis.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
142
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
244
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
58
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
95
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
76
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
639